Comparison

MK-677 vs CJC-1295 DAC

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

MK-677

Also: Ibutamoren, Nutrobal

Clinical Trials

An orally active growth hormone secretagogue that mimics ghrelin. Although technically not a peptide, it is frequently discussed alongside GH peptides due to similar effects.

Growth HormoneHuman Trials
CJC-1295 DAC

Also: Modified GRF 1-29 DAC, Drug Affinity Complex CJC

Clinical Trials

A long-acting GHRH analog with Drug Affinity Complex for extended half-life. Provides sustained GH elevation for days with single injection.

Growth HormoneHuman Trials

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.

Detailed Comparison

AttributeMK-677CJC-1295 DAC
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionMK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it is orally bioavailable and has a long half-life providing 24-hour GH elevation.CJC-1295 DAC contains a reactive linker that binds to albumin after injection. This extends half-life from minutes to 6-8 days, providing sustained GHRH stimulation and GH/IGF-1 elevation.
Common Dosing
10-25 mg daily
Once daily, often before bed
Limited community data available
See research protocols
AdministrationOralSubcutaneous injection
Typical Duration8-12 weeks or longer8-12 weeks typical
Best Time to TakeBefore bedBefore bed or morning (fasted)
Possible Side Effects
May vary by individual
  • Increased appetite and hunger
  • Weight gain
  • Water retention
  • Insulin resistance
  • Elevated blood glucose
  • +3 more
  • Generally well-tolerated
  • Injection site reactions
  • Facial flushing
  • Water retention
  • Headache
  • +3 more
Research SummaryStudies show increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. However, a clinical trial was stopped early due to heart failure concerns in elderly patients. FDA lists MK-677 as having significant safety risks. Never received FDA approval.Studies show sustained 2-10 fold increase in GH levels lasting several days. Single weekly injection maintains elevated IGF-1. Less physiologic than pulsatile protocols but more convenient.

Frequently Asked Questions: MK-677 vs CJC-1295 DAC

What is the difference between MK-677 and CJC-1295 DAC?

MK-677 is a growth hormone peptide that an orally active growth hormone secretagogue that mimics ghrelin. although technically not a peptide, it is frequently discussed alongside gh peptides due to similar effects. CJC-1295 DAC is a growth hormone peptide that a long-acting ghrh analog with drug affinity complex for extended half-life. provides sustained gh elevation for days with single injection. The main differences lie in their mechanisms of action and clinical applications.

Which is better, MK-677 or CJC-1295 DAC?

Neither is universally "better" - the choice depends on your specific goals. MK-677 is typically used for growth hormone purposes, while CJC-1295 DAC is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can MK-677 and CJC-1295 DAC be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using MK-677 and CJC-1295 DAC together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of MK-677 and CJC-1295 DAC is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.